Precision for Medicine Acquires ACT Oncology         

JOSEPH A. PARKS

Vice-President, Quality and Compliance

Joe has over 30 years of diverse professional experience in the pharmaceutical industry providing executive management and development leadership for pharmaceutical/biotechnology companies and global CROs. Joe is currently the Vice President, Quality and Compliance and has been with ACT Oncology since 2011. In this role he works directly with clients providing Executive Leadership on programs/trials and guidance to ensure quality and compliance in all phases of drug development. Joe also serves as ACT Oncology’s Compliance Officer is a member of the Executive Team providing oversight, management and guidance to ACT Oncology, LLC.

Throughout his career, Joe has provided corporate, project management, cross-functional team, clinical development and operational leadership for early-mid-late stage clinical development programs and alliance-based/Joint Committee partnerships. Joe has extensive experience with SOP development, ICH/GCP guidelines, compliance inspection readiness, vendor selection, partnering and management. He has participated in several pre-IND meetings, IND submissions, 5 New Drug Applications (NDA eCTD format) and 2 Marketing Authorization Applications (MAA eCTD format), most recently with Qsymia® NDA/MAA submissions and Stendra® NDA.

Joe is professionally credentialed as a Registered Quality Assurance Professional (RQAP-GCP) for professionals working in Good Clinical Practices. This credential further demonstrates Joe’s knowledge of the regulations/guidelines and how they are applied as well has his commitment to high quality standards within the industry.

Joe ParksLowRes_0179_033

We're changing our name and website to reflect our exciting new capabilities since joining Precision for Medicine. Please visit us at precisionforoncology.com to see how we’re delivering the next generation of CRO services for oncology innovators.